New study explores best diabetes treatment for black patients
NCT ID NCT07325435
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how two types of diabetes medicines affect the pancreas in Black patients with type 2 diabetes. About 60 adults will take either a GLP-1 receptor agonist or an SGLT-2 inhibitor for 16 weeks. The goal is to see which drug better helps the pancreas make insulin, since Black patients may have a unique ability to recover insulin production.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SUNY Downstate Health Sciences University
Brooklyn, New York, 11203, United States